Guochao Liang – Trademark Portfolio

Entity Type: 01

Guochao Liang holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include RESIGO and BIEYUNJIAN. The owner is based in Qinzhou City, Guangxi.

No. 137, Tunxiao Village

Xinxiao Cunwei, Dasi Town, Qinbei Dist

Qinzhou City, Guangxi 535000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RESIGO
RESIGO
Pending 2026
RESIGO
RESIGO
Registered 2021

Trademark Classifications

Guochao Liang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

21
Housewares (2 filings)

Household or kitchen utensils and containers; combs and sponges; brushes

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Guochao Liang have?

Guochao Liang has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does Guochao Liang file in?

Guochao Liang files trademarks across 2 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.

What are Guochao Liang's most well-known trademarks?

Guochao Liang's registered trademark portfolio includes well-known marks such as RESIGO and BIEYUNJIAN. These are among 2 currently registered trademarks in the portfolio.

What is Guochao Liang's trademark registration success rate?

Guochao Liang has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.